Resumen

PELAEZ-LUNA, Mario et al. Guide for the management of antithrombotic therapy during endoscopic procedures. Endoscopia [online]. 2019, vol.31, n.2, pp.58-76.  Epub 25-Oct-2021. ISSN 2444-6483.  https://doi.org/10.24875/end.m19000007.

The use of antithrombotic therapies and non-steroid anti-inflammatory drugs has increased worldwide and with it the risk of presenting a bleeding complication. The group of patients undergoing an invasive procedure such as a gastrointestinal endoscopy are at a higher risk of peri-procedural bleeding complications. However, in those patients receiving anti-thrombotic therapy scheduled for a gastrointestinal endoscopy the risk of bleeding must be weighted against the risk of a thrombo-embolic event while the patients are off the antithrombotic treatment. Antithrombotic drug management in the peri-endoscopic time has become more complex due to the appearance of the new direct action anticoagulants. Although several international guidelines and systematic reviews on the topic are available, its applicability and availability in Mexico are limited, considering language barriers and drug and technology availability, among others. This lead the Asociación Mexicana de Endoscopia Gastrointestinal to summon a group of gastroenterologists, endoscopists, cardiologists and hematologists to assess and review current scientific evidence with the aim to develop and propose a series of recommendations for the management of anti-thrombotic therapy before, during and after and endoscopic procedure.

Palabras llave : Endoscopy; Anticoagulants; Antiplatelet therapy; Direct action anticoagulants; Gastrointestinal bleeding; Thrombosis; Embolism.